Showing results (71-80 of 232) with videos related to
Sort By:
Pageof 24
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 11, 2020
Premorbid functional reserve modulates the effect of rehabilitation in multiple sclerosisLetizia Castelli, Laura De Giglio, Shalom Haggiag, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 13, 2018
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre studyMarloes Hj Hagens, Jessica Burggraaff, Iris D Kilsdonk, et al.Annals of Neurology|April 15, 2020
Longitudinal Assessment of Multiple Sclerosis with the Brain-Age ParadigmJames H Cole, Joel Raffel, Tim Friede, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 11, 2011
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosisLuca Prosperini, Costanza Giannì, Laura Leonardi, et al.Frontiers in Neurology|August 1, 2022
Bridging Therapies With Injectable Immunomodulatory Drugs in the Management of Multiple Sclerosis: A Delphi Survey of an Italian Expert Panel of NeurologistsGirolama Alessandra Marfia, Diego Centonze, Marco Salvetti, et al.Journal of Neurology|June 6, 2025
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspectiveChiara Zanetta, Claudio Gasperini, Maria Pia Amato, et al.Journal of Neurology|February 21, 2021
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapyRosa Cortese, Luca Prosperini, Alessandro Stasolla, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|March 5, 2010
Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosisNicola De Stefano, François Curtin, Bettina Stubinski, et al.Brain : a Journal of Neurology|August 29, 2023
Prognostic value of single-subject grey matter networks in early multiple sclerosisVinzenz Fleischer, Gabriel Gonzalez-Escamilla, Deborah Pareto, et al.The Lancet. Neurology|December 26, 2017
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective studyMassimo Filippi, Paolo Preziosa, Alessandro Meani, et al.Pageof 24